TICKERNOMICS Sign up
Last Update: 2023-12-23 06:00:50
COMPASS Pathways plc ( CMPS ) https://compasspathways.com
8.02USD
Sector:
Healthcare
Industry:
Medical Care Facilities
Country:
United Kingdom
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-5.09%
CMPS
SPY
30.72%
-86.45%
CMPS
SPY
112.82%
CMPS
0.00%
SPY
201.04%
CMPS
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
391.11
177.71
0.47
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-3.35
0.00
1.54
-27.45
0.00
-1.36
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
3.86
-56.04
-56.72
0.00
Other Earnings and Cash Flow Stats:
COMPASS Pathways plc ( CMPS ) Net Income TTM ($MM) is -106.89
COMPASS Pathways plc ( CMPS ) Operating Income TTM ($MM) is -123.58
COMPASS Pathways plc ( CMPS ) Owners' Earnings Annual ($MM) is 0.00
COMPASS Pathways plc ( CMPS ) Current Price to Owners' Earnings ratio is 0.00
COMPASS Pathways plc ( CMPS ) EBITDA TTM ($MM) is -123.17
COMPASS Pathways plc ( CMPS ) EBITDA Margin is 0.00%
Capital Allocation:
COMPASS Pathways plc ( CMPS ) has paid 0.00 dividends per share and bought back -7.107249 million shares in the past 12 months
COMPASS Pathways plc ( CMPS ) has increased its debt by 32.38 million USD in the last 12 months
Capital Structure:
COMPASS Pathways plc ( CMPS ) Interest-bearing Debt ($MM) as of last quarter is 34
COMPASS Pathways plc ( CMPS ) Annual Working Capital Investments ($MM) are -55
COMPASS Pathways plc ( CMPS ) Book Value ($MM) as of last quarter is 253
COMPASS Pathways plc ( CMPS ) Debt/Capital as of last quarter is 13%
Other Balance Sheet Stats:
COMPASS Pathways plc ( CMPS ) has 248 million in cash on hand as of last quarter
COMPASS Pathways plc ( CMPS ) has 15 million of liabilities due within 12 months, and long term debt 28 as of last quarter
COMPASS Pathways plc ( CMPS ) has 49 common shares outstanding as of last quarter
COMPASS Pathways plc ( CMPS ) has 0 million USD of preferred stock value
Academic Scores:
COMPASS Pathways plc ( CMPS ) Altman Z-Score is 3.14 as of last quarter
COMPASS Pathways plc ( CMPS ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
COMPASS Pathways plc ( CMPS ) largest shareholder is LAURION CAPITAL MANAGEMENT LP owning 510907 shares at 4.10 ($MM) value
Ekaterina Malievskaia(an insider) Sold 2855 shares of COMPASS Pathways plc ( CMPS ) for the amount of $22326.10 on 2023-12-13
16.57% of COMPASS Pathways plc ( CMPS ) is held by insiders, and 36.81% is held by institutions
COMPASS Pathways plc ( CMPS ) went public on 2020-09-18
Other COMPASS Pathways plc ( CMPS ) financial metrics:
FCF:-109.26
Unlevered Free Cash Flow:0.00
EPS:-2.69
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-52.74
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About COMPASS Pathways plc ( CMPS ) :
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.